文献速递慢阻肺哮喘

从不吸烟与吸烟人群中慢性阻塞性肺疾病的特征比较:基于人群队列研究

Characterisation of chronic obstructive pulmonary disease (COPD) in never-smokers and ever-smokers from a population-based cohort
RSS 订阅 · BMJ Open Respiratory Research

基于瑞典SCAPIS人群队列,比较从不吸烟COPD患者(n=154)与四组对照的临床特征。从不吸烟COPD患者呼吸道症状更多、健康状况更差,但较吸烟COPD患者症状更少、气流受限更轻;其自报哮喘更多,气传过敏原IgE致敏、FeNO及血嗜酸性粒细胞更高。排除自报哮喘者后,从不吸烟COPD患者仍有更多喘息、咳嗽及更高FeNO,提示可能为独特临床表型。

要点

  • 从不吸烟COPD患者较从不吸烟肺功能正常者症状更多、健康状况更差。
  • 从不吸烟COPD患者较吸烟COPD患者症状更少、气流受限更轻、健康状况更好。
  • 从不吸烟COPD患者2型炎症标志物升高,可能需不同的治疗与随访策略。

核心结论

  • 从不吸烟COPD患者呼吸道症状更多且2型炎症标志物升高,可能代表不同于吸烟相关COPD的独特临床表型。

研究设计与样本

  • 基于瑞典SCAPIS人群队列,纳入从不吸烟COPD患者n=154(平均年龄60岁),与四组对照比较。
  • 对照包括从不吸烟肺功能正常者n=281、当前吸烟肺功能正常者n=97、戒烟COPD患者n=103及当前吸烟COPD患者n=55。
  • COPD定义为支气管舒张后FEV1/FVC低于正常下限(LLN)。

主要发现

  • 从不吸烟COPD组较从不吸烟肺功能正常组呼吸道症状更多、健康状况更差。
  • 从不吸烟COPD组较戒烟及当前吸烟COPD组症状更少、气流受限更轻、健康状况更好。
  • 从不吸烟COPD组自报哮喘更多,气传过敏原混合IgE致敏率更高,FeNO几何均值及血嗜酸性粒细胞计数更高。
  • 排除自报哮喘者后,从不吸烟COPD组仍有更多喘息、咳嗽及更高FeNO。

临床怎么用

  • 对从不吸烟COPD患者应关注2型炎症标志物(FeNO、血嗜酸性粒细胞、IgE致敏)及哮喘病史。
  • 从不吸烟COPD患者可能需要与吸烟相关COPD不同的治疗与随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Chronic obstructive pulmonary disease (COPD) in never-smokers may have other clinical characteristics than tobacco smoking-related COPD. Research question What are the risk factors, biomarkers, respiratory symptoms and health status in never-smoking individuals with COPD? Study design and methods We investigated never-smokers with COPD (n=154, mean age 60 years) from the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS), and compared them with four control groups: never-smokers with normal lung function (n=281), current smokers with normal lung function (n=97), ex-smokers with COPD (n=103) and current smokers with COPD (n=55). COPD was defined as forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) less than the lower limit of normal (LNN) after bronchodilation. We examined fractional exhaled nitric oxide (FeNO), blood biomarkers, respiratory symptoms, health status, medical history and living conditions. Results The never-smoker COPD group reported more respiratory symptoms and worse health status than never-smokers with normal lung function, but fewer symptoms, milder airflow limitation and better health status compared with ex-smokers and smokers with COPD. Never-smokers with COPD had more self-reported asthma. Moreover, never-smokers with COPD had higher Immunoglobulin E sensitisations to a mix of aeroallergens, higher geometrical mean FeNO levels and blood eosinophil counts than never-smokers with normal lung function. When participants with self-reported asthma were excluded, never-smokers with COPD still had more wheeze, cough and higher FeNO. Conclusion Never-smokers with COPD had more respiratory symptoms and elevated markers of type-2 inflammation, suggesting they might represent a distinct clinical phenotype which may differ from smoking-related COPD. They may therefore need to be treated and followed differently. Trial registration number NCT03049202 .

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Characterisation of chronic obstructive pulmonary disease (COPD) in never-smokers and ever-smokers from a population-based cohort

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。